Back

Should all diabetic patients be treated with SGLT2 inhibitors?

28 August 2021 (12:00 - 12:15)
Organised by:
Congress Presentation Part of: Meet the Experts: new cardiorenal pharmacotherapy for diabetes Pharmacology and Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Francesco Cosentino

Karolinska University Hospital, Stockholm (Sweden)

2 More presentations in this session

Presentation thumbnail
Should all diabetic patients be treated with GLP-1 agonists?
Associate Professor L. Mellbin (Stockholm, SE)
Slides Video
Presentation thumbnail
Meet the Experts: new cardiorenal pharmacotherapy for diabetes – discussion.

Access the full session

Session thumbnail
Meet the Experts: new cardiorenal pharmacotherapy for diabetes
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 12:00 CET
You may be interested in
thumbnail
Congress Session
No time like the present: heart failure in the hospital setting
30 August 2024
thumbnail
Congress Presentation
Sodium-glucose cotransporter-2 inhibitors and their combination with glucagon like peptide-1 receptor agonists improve endothelial glycocalyx and arterial stiffness in type-2 diabetes
28 August 2020
thumbnail
Webinar
Diabetes and ACS - enhancing post-discharge outcomes after primary PCI
26 May 2025
thumbnail
Congress Presentation
Effects of urinary tract infection and stopping sodium-glucose cotranspoter-2 inhibitors in patients with type 2 diabetes mellitus: a population-based study
26 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources